Dibucaine topical Pregnancy and Breastfeeding Warnings
Medically reviewed by Drugs.com. Last updated on May 10, 2023.
Dibucaine topical is also known as: Nupercainal, Rectacaine
Dibucaine topical Pregnancy Warnings
Dibucaine topical has been assigned to pregnancy category C by the FDA. Animal study data have not been reported. There are no controlled data in human pregnancy. Caution is recommended when dibucaine topical is administered during pregnancy.
Dibucaine topical Breastfeeding Warnings
There are no data on the excretion of dibucaine into human milk. Caution is recommended when dibucaine topical is administered to a nursing mother.
See also
References for pregnancy information
- "Multum Information Services, Inc. Expert Review Panel"
- "Product Information. Nupercainal (dibucaine topical)." Ciba-Geigy Pharmaceuticals (2001):
References for breastfeeding information
- "Multum Information Services, Inc. Expert Review Panel"
- "Product Information. Nupercainal (dibucaine topical)." Ciba-Geigy Pharmaceuticals (2001):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.